United Therapeutics (UTHR) Surpasses Q4 Earnings and Revenue Estimates
Portfolio Pulse from
United Therapeutics (UTHR) reported Q4 earnings of $6.19 per share, surpassing the Zacks Consensus Estimate of $6.10. This marks an increase from $4.36 per share a year ago.
February 26, 2025 | 1:45 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
United Therapeutics reported Q4 earnings of $6.19 per share, exceeding expectations and showing growth from last year's $4.36 per share.
The company's earnings per share exceeded analyst expectations and showed significant growth compared to the previous year, which is likely to positively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100